Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00043316 · ClinicalTrials.gov registry record · Phase 1

Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis

A Phase 1 study of Cystic Fibrosis, sponsored by InterMune.

Completed
Registry status
Phase 1
Development phase
66
Enrollment target
17
Study locations

NCT00043316 is a Phase 1 study of Cystic Fibrosis that has completed, run by InterMune. The registered enrollment target is 66 participants, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (63% lower). The trial reports 17 study locations across 12 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00043316, a Phase 1 study of Cystic Fibrosis, has completed, sponsored by InterMune.

COMPLETED
Registry status
Phase 1
Development phase
66 participants
Enrollment target
17
Study locations

Study Summary

The purpose of this research study is to evaluate the safety and effectiveness of Interferon gamma-1b (IFN-g 1b) on lung function when given to patients with cystic fibrosis by inhalation (breathed into the lungs) three times a week for 12 weeks. The FDA has not approved Interferon gamma-1b for use with cystic fibrosis patients, which is the condition being examined in this study.

Conditions Studied

Cystic Fibrosis

Interventions

  • DRUG interferon gamma-1b

Study Locations (17)

California

  • - Palo Alto
  • - Sacramento
  • - San Diego
  • - San Francisco

Florida

  • - Daytona Beach
  • - Orlando

Texas

  • - Lackland Air Force Base
  • - Tyler

Alabama

  • - Birmingham

Arizona

  • - Phoenix

Colorado

  • - Denver

Illinois

  • - Chicago

Louisiana

  • - New Orleans

Trial Details

FieldValue
Enrollment Target 66 participants
Start Date 2001-02
Est. Completion 2002-10
Phase Phase 1

Sponsor

InterMune

11 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00043316

The ClinicalTrials.gov registry entry for NCT00043316 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 66 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 179-participant average among 169 other Cystic Fibrosis trials with a reported enrollment target (63% lower). The listed sponsor is InterMune, which has 11 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cystic Fibrosis appearing as the primary indexed condition, and to 1 intervention - of which interferon gamma-1b is the first listed.

NCT00043316 reports 17 study locations spanning 12 distinct geographic areas - top geographies include California, Florida, Texas.

Frequently Asked Questions

What is clinical trial NCT00043316 about?

NCT00043316 is a clinical study titled "Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis". The purpose of this research study is to evaluate the safety and effectiveness of Interferon gamma-1b (IFN-g 1b) on lung function when given to patients with cystic fibrosis by inhalation (breathed into the lungs) three times a week for 12 weeks. The FDA has not approved Interferon gamma-1b for use...

What is the current status of trial NCT00043316?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 66 participants. The study started on 2001-02. Estimated completion is 2002-10.

What conditions does trial NCT00043316 study?

This clinical trial studies the following conditions: Cystic Fibrosis.

What interventions are being tested in trial NCT00043316?

The interventions under investigation include: interferon gamma-1b (DRUG).

Who is sponsoring clinical trial NCT00043316?

This trial is sponsored by InterMune, which has 11 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00043316 being conducted?

This trial has 17 study locations across Alabama, Arizona, California, Colorado, Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Cystic Fibrosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Cystic Fibrosis

All registered trials for this condition

Alabama

All trials with a study site in Alabama

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.